LLTP Insider Trading Activity and SEC Form 4 Filings
LLTP insider trading summary
No open-market insider purchases or sales of Lightlake Therapeutics Inc. (LLTP) have been reported on SEC Form 4 in the past 12 months.
Latest LLTP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 15, 2015 | Michael Sinclair | Executive Chairman | Sell | $6K (1,700 @ $3.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.